CytoReason, Pfizer ink $110M, 5-year extension of AI-powered drug development deal
Pfizer extends partnership with CytoReason to use AI for drug discovery
AI becomes higher priority for drug discovery with Pfizer, CytoReason deal extension
CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development
CytoReason, Pfizer sign $110m extended AI-based drug development deal
CytoReason Expands its 2019 Collaboration with Pfizer for AI Drug Development
Touting nine-figure deal package, Pfizer extends collaboration with AI partner
CytoReason Extends multi-Year Partnership with Pfizer
Epic hits a crossroads, judge rules on UnitedHealth’s Change bid, & Meta faces health data pressure
CytoReason Shoots For $110M Net With Pfizer Partnership
